Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,387 | 793 | 98.3% |
| Education | $133.81 | 5 | 0.9% |
| Gift | $120.42 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,228 | 121 | $0 (2024) |
| Astellas Pharma US Inc | $1,745 | 91 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $1,127 | 56 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $1,094 | 53 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,081 | 61 | $0 (2024) |
| PFIZER INC. | $916.66 | 55 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $761.60 | 38 | $0 (2024) |
| ABBVIE INC. | $723.46 | 36 | $0 (2024) |
| Allergan, Inc. | $591.64 | 29 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $544.31 | 36 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,744 | 84 | Sumitomo Pharma America, Inc. ($541.73) |
| 2023 | $2,331 | 113 | Sumitomo Pharma America, Inc. ($585.44) |
| 2022 | $1,873 | 103 | Janssen Biotech, Inc. ($321.21) |
| 2021 | $1,428 | 79 | Myovant Sciences Inc. ($237.82) |
| 2020 | $981.95 | 48 | Endo Pharmaceuticals Inc. ($154.57) |
| 2019 | $2,613 | 143 | Janssen Biotech, Inc. ($422.39) |
| 2018 | $2,056 | 125 | Janssen Biotech, Inc. ($461.50) |
| 2017 | $1,613 | 104 | Astellas Pharma US Inc ($298.83) |
All Payment Transactions
799 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: UROLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/09/2024 | SRS Medical Systems, Inc. | CT3000 Pro Base Unit (Device), UroCuff-DC Disposable, Single | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Urology | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: HORMONE THERAPY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 10/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Oncology | ||||||
| 10/23/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 09/13/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,375 | 2,172 | $324,447 | $75,567 |
| 2022 | 24 | 1,497 | 2,379 | $457,986 | $99,984 |
| 2021 | 20 | 1,485 | 2,229 | $385,280 | $84,640 |
| 2020 | 34 | 1,839 | 3,389 | $565,835 | $129,840 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 373 | $164,579 | $37,756 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 200 | $62,669 | $14,410 | 23.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 29 | 31 | $30,262 | $6,138 | 20.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 141 | 192 | $10,593 | $3,460 | 32.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 155 | 242 | $11,517 | $2,292 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $10,414 | $2,098 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 272 | 550 | $5,742 | $1,858 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 111 | 150 | $1,350 | $1,260 | 93.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 23 | 27 | $5,665 | $1,220 | 21.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 24 | 41 | $3,175 | $1,037 | 32.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 68 | 94 | $2,276 | $743.54 | 32.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 49 | 52 | $6,858 | $574.36 | 8.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $2,372 | $541.70 | 22.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 16 | $1,930 | $529.12 | 27.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 35 | $1,109 | $362.25 | 32.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 31 | 37 | $939.06 | $306.73 | 32.7% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 15 | 35 | $908.25 | $296.67 | 32.7% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 15 | 15 | $827.55 | $270.30 | 32.7% |
| 87088 | Bacterial urine culture | Office | 2023 | 16 | 26 | $631.02 | $206.18 | 32.7% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 16 | 26 | $630.24 | $205.92 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 319 | $149,120 | $33,946 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 280 | $92,585 | $21,519 | 23.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 47 | 56 | $64,580 | $12,157 | 18.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 15 | 15 | $20,883 | $5,612 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $18,328 | $3,846 | 21.0% |
About Dr. Eric Kreutzer, M.D
Dr. Eric Kreutzer, M.D is a Urology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407831324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Kreutzer, M.D has received a total of $14,641 in payments from pharmaceutical and medical device companies, with $1,744 received in 2024. These payments were reported across 799 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($14,387).
As a Medicare-enrolled provider, Kreutzer has provided services to 6,196 Medicare beneficiaries, totaling 10,169 services with total Medicare billing of $390,031. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Bronx, NY
- Active Since 12/13/2005
- Last Updated 11/24/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407831324
Products in Payments
- XTANDI (Drug) $1,202
- ERLEADA (Drug) $1,129
- GEMTESA (Drug) $1,112
- XIAFLEX (Biological) $1,081
- Erleada (Drug) $1,020
- PROVENGE (Drug) $797.92
- Nubeqa (Drug) $696.42
- ORGOVYX (Drug) $681.94
- ELIGARD (Drug) $613.70
- Xtandi (Drug) $455.12
- Myrbetriq (Drug) $407.70
- BOTOX (Biological) $388.61
- Xofigo (Drug) $384.78
- MYRBETRIQ (Drug) $377.23
- FIRMAGON (Drug) $359.11
- KEYTRUDA (Biological) $292.77
- LUPRON DEPOT (Drug) $284.88
- ZYTIGA (Drug) $224.83
- Natesto (Drug) $185.90
- UroLift (Device) $144.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Bronx
Pedro Maria, D.o, D.O
Urology — Payments: $210,728
Dr. Glen Mcwilliams, M.d, M.D
Urology — Payments: $115,960
Lanna Cheuck
Urology — Payments: $46,439
Alexander Small, Md, MD
Urology — Payments: $31,583
Kara Watts, Md, MD
Urology — Payments: $18,359
Reza Ghavamian, Md, MD
Urology — Payments: $14,438